Pfizer Inc., current enterprise value calculation

Current share price (P)	$25.21
No. shares of common stock outstanding	5,667,340,414
US$ in millions
Common equity (market value)¹	142,874)
Add: Equity attributable to noncontrolling interests (per books)	294)
Total equity	143,168)
Add: Short-term borrowings, including current portion of long-term debt (per books)	6,946)
Add: Long-term debt, excluding current portion (per books)	57,405)
Total equity and debt	207,519)
Less: Cash and cash equivalents	1,043)
Less: Short-term investments	19,434)
Enterprise value (EV)	187,042)

¹ Common equity (market value) = Share price × No. shares of common stock outstanding
= 25.21 × 5,667,340,414

Pfizer Inc., EV calculation

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Share price^1, 2	$26.10	$27.55	$42.30	$45.96	$33.82
No. shares of common stock outstanding¹	5,667,340,414	5,646,778,425	5,619,074,621	5,623,346,471	5,577,629,491
US$ in millions
Common equity (market value)³	147,918)	155,569)	237,687)	258,449)	188,635)
Add: Equity attributable to noncontrolling interests (book value)	294)	274)	255)	261)	235)
Total equity	148,212)	155,843)	237,942)	258,710)	188,870)
Add: Short-term borrowings, including current portion of long-term debt (book value)	6,946)	10,350)	2,945)	2,241)	2,703)
Add: Long-term debt, excluding current portion (book value)	57,405)	61,538)	32,884)	36,195)	37,133)
Total equity and debt	212,563)	227,731)	273,771)	297,146)	228,706)
Less: Cash and cash equivalents	1,043)	2,853)	416)	1,944)	1,784)
Less: Short-term investments	19,434)	9,837)	22,316)	29,125)	10,437)
Enterprise value (EV)	192,086)	215,041)	251,039)	266,077)	216,485)

¹ Data adjusted for splits and stock dividends.

² Closing price as at the filing date of Pfizer Inc. Annual Report.

³ 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 26.10 × 5,667,340,414

Download chart

Item	Description	The company
EV	Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments.	Pfizer Inc. EV decreased from 2022 to 2023 and from 2023 to 2024.

Pfizer Inc. (NYSE:PFE)

Enterprise Value (EV)